• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fluoropyrimidine treatment of ocular cicatricial disease.

作者信息

Heath T D, Lopez N G, Lewis G P, Stern W H

出版信息

Invest Ophthalmol Vis Sci. 1986 Jun;27(6):940-5.

PMID:2940202
Abstract

The authors have studied the antiproliferative and anticontractile effects of fluorouracil, fluorouridine, and fluorodeoxyuridine on rabbit dermal fibroblasts. All three drugs have antiproliferative effects, the order of their efficacy being fluorodeoxyuridine greater than fluorouridine greater than fluorouracil. In contrast, only fluorouridine and fluorouracil have anticontractile effects. Fluorouridine requires less time of exposure and has greater anticontractile effects than fluorouracil. Thymidine eliminates the antiproliferative effects of fluorodeoxyuridine, but has no effect on either the antiproliferative or anticontractile effects of fluorouracil and fluorouridine. These results suggest that the anticontractile effects of the fluoropyrimidines are caused by their incorporation into RNA and not by the inhibition of DNA synthesis. Metabolites of fluorouracil may provide enhanced control of cell proliferation and contractility in the management of ocular disorders such as proliferative vitreoretinopathy and glaucoma.

摘要

相似文献

1
Fluoropyrimidine treatment of ocular cicatricial disease.
Invest Ophthalmol Vis Sci. 1986 Jun;27(6):940-5.
2
The effects of the fluorinated pyrimidines FUR, FUdR, FUMP, and FdUMP on human Tenon's fibroblasts.
Invest Ophthalmol Vis Sci. 1991 Aug;32(9):2599-609.
3
Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines.眼内增殖性疾病治疗药物的选择。II. 氟嘧啶类药物不同的抗增殖活性。
Arch Ophthalmol. 1987 Mar;105(3):396-9. doi: 10.1001/archopht.1987.01060030116039.
4
Selectivity of action of 5-FU: biochemical basis.5-氟尿嘧啶作用的选择性:生化基础
Bull Cancer. 1979;66(1):43-7.
5
Antiproliferative and anticontractile effects of liposome encapsulated fluoroorotate.脂质体包裹氟乳清酸盐的抗增殖和抗收缩作用
Invest Ophthalmol Vis Sci. 1987 Aug;28(8):1365-72.
6
Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.培养的人结肠癌细胞中细胞致死率与5-氟尿嘧啶和5-氟尿苷掺入核RNA的相关性。
Mol Pharmacol. 1982 Mar;21(2):468-73.
7
A comparison of 5-fluorouridine and 5-fluorouracil in an experimental model for the treatment of vitreoretinal scarring.
Curr Eye Res. 1993 May;12(5):397-401. doi: 10.3109/02713689309024621.
8
Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.
Med Oncol Tumor Pharmacother. 1986;3(2):111-8. doi: 10.1007/BF02934563.
9
Selection of therapeutic agents for intraocular proliferative disease 3. Effects of fluoropyrimidines on cell-mediated contraction of human fibroblasts.眼内增殖性疾病治疗药物的选择 3. 氟嘧啶对人成纤维细胞细胞介导收缩的影响。
Exp Eye Res. 1989 Mar;48(3):321-8. doi: 10.1016/s0014-4835(89)80001-6.
10
Ocular cicatricial disease. Drug effects in vitro on cell proliferation, contraction, and viability.眼部瘢痕性疾病。药物对细胞增殖、收缩及活力的体外作用。
Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1245-51.

引用本文的文献

1
The use of a liposome-encapsulated 5-fluoroorotate for glaucoma surgery: I. Animal studies.脂质体包裹的5-氟乳清酸在青光眼手术中的应用:I. 动物研究。
Trans Am Ophthalmol Soc. 1989;87:489-514.